Subscribe
Healthcare

Future of cancer treatment uncertain with mRNA vaccine cuts

By Gabrielle M. Etzel
Published
Add Washington Examiner on Google

The fate of an important breakthrough in cancer immunotherapy treatment remains in the balance following an announcement earlier this week that the Department of Health and Human Services will cancel several research projects related to mRNA vaccines.

HHS Secretary Robert F. Kennedy Jr. sent shockwaves through the public health community Tuesday when he announced that the Biomedical Advanced Research and Development Authority will cancel 22 projects related to mRNA vaccine development for COVID-19, influenza, and other upper respiratory viruses.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

Bill Cassidy Bird Flu Cancer Covid vaccination COVID-19 Department of Health and Human Services Healthcare Investigations Robert F. Kennedy Jr. Vaccines Washington D.C.